More Anthrax Vaccine Contracts Issued: 44.75 Million Doses of BioThrax Over 5 Years

Brandon Turbeville

Activist Post

October 5, 2011

On September 22, 2011, I wrote an article entitled, Grants Issued For Next-Generation Anthrax Vaccine; False Flag to Come, Or More Wasted Money? in which I discussed the recent announcement that the Department of Health and Human Services (HHS) was granting the Biomedical Advanced Research and Developmental Authority (BARDA) millions of dollars for the purpose of creating a “next-generation anthrax vaccine and a new type of antitoxin.” 

In this announcement, it was reported that BARDA would be contracting out the work in regards to these projects to two companies, Vaxin Inc. out of Rockville, Maryland and Elusys Therapeutics out of Pine Brook, New Jersey. 

I also discussed the concerns related to Anthrax vaccine/antitoxin production in relation to the potential signaling of a false flag attack. This perspective is related to the fact that the original and much-touted anthrax attacks of 2001 were not the result of fundamentalist Muslim terrorism but the direct result of US government involvement. 

It is important to understand, as addressed in the aforementioned article, the context in which the new vaccine production is being implemented. An example would be Barack Obama’s now famous Executive Order (EO) 13527 which directly relates to a “bioterrorist” attack and contains language that has led many to speculate as to whether it also relates to forced vaccination programs. Not only that, but it is also important to understand the role government has played in creating and exploiting just these types of situations. 

One should also be seriously concerned about the obvious adverse health effects created by the previously administered anthrax vaccines, particularly in American servicemen, and how they relate to the new vaccines being produced. 

I highly recommend that the reader go back to my previous article and read the information presented there for some brief background related to the concern of a potential false flag attack in regards to the recent announcement of contracts to produce new anthrax vaccines. 

Grants Issued for Next-Generation Anthrax Vaccine -- False Flag to Come, Or More Wasted Money?

Brandon Turbeville

Activist Post
September 22, 2011

On September 20, the Department of Health and Human Services (HHS) announced that it had awarded millions of dollars worth of grants to the Biomedical Advanced Research and Developmental Authority (BARDA) for the purpose of supporting the “advanced development of a novel next-generation anthrax vaccine and a new type of anthrax antitoxin.”

Although the announcement has received very little attention in the media, it is nonetheless concerning to those of us who are not apt to trust that every move made by our government is for our benefit.

The agency receiving the grants, BARDA, is located within the Office of the Assistant Secretary for Preparedness and Response, which itself is a division of HHS. BARDA manages Project BioShield, which “includes the procurement and advanced development of medical countermeasures for chemical, biological, radiological, and nuclear agents, as well as the advanced development and procurement of medical countermeasures for pandemic influenza and other emerging infectious diseases that fall outside the auspices of Project BioShield.” BARDA also oversees the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE). 


As one can see, the research grants given to BARDA through HHS are emergency-minded in nature; the idea behind these particular contracts being the development of an anthrax vaccine or treatment in the event of an anthrax attack on the United States. The money provided to BARDA will be funneled from the agency to two vaccine companies who will actually be the ones to conduct the studies and manufacturing processes for the up and coming vaccines.